$NVEC

BAKER DANIEL A sold $2.1M of NVEC

BAKER DANIEL A sold 21,140 shares of NVE CORP /NEW/ (NVEC) at an average of $101.49 ($101.00–$101.54, $2.15M total) across 2 trades on 2026-09-08.

Original reporting
SEC EDGAR · BAKER DANIEL A
Published Sep 10, 2026, 1:37 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 2:05 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NVEC
Bearish
medium confidence
Mentioned
$NVEC
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NVECBearishLow
01

Why it matters

The disclosed sale provides fresh data for investors assessing insider sentiment.

02

Market read

The filing offers a new data point for NVEC investors, but overall market impact is limited.

03

What to watch

Potential tax planning or diversification motives behind the director's sale.

Relevance 6/10Novelty 4/10Timing: sale reported on 2026-09-08

Background

Form 4 filings disclose insider transactions; a director's sale is publicly reported.

Company-level read

Ticker impact

$NVECBearishMedium confidence
Context

Director Baker Daniel A sold 21,140 shares of NVE Corp for $2.1M on 2026-09-08, reducing his stake to 17,932 shares.

Expected impact

Possible modest downside pressure over the next few days.

Evidence & confidence

A $2.1M sale by a director is material enough to attract attention but not large enough to drive a major move.

Market effects

Minimal impact on the renewable energy sector; insider activity is company‑specific.

No broader regional effect.

Limited to investors tracking NVEC.

Counterpoint

The sale could be unrelated to fundamentals; the stock may remain stable.

Key entities

  • Baker Daniel A

    Director of NVE Corp who sold shares.

  • NVE Corp

    Issuer of the shares sold.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVECMed

NVE (NVEC) Q1 2027 Earnings Call Transcript

NVE Corp (NVEC) Q1 2027 results showed net income up 79% to $6.39 million, or $1.32 per diluted share, on higher revenue. Operating expenses rose mainly from performance-based compensation, while expense as a % of revenue fell to 15% from 19%. Cash and marketable securities rose to $43.9 million. The company launched two MRI-safe wafer-level chip scale sensors and announced CEO succession.

$NVECMed

NVE CORP /NEW/ (NVEC): Results of Operations and Financial Condition

NVE CORP /NEW/ (NVEC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 nve_ex99z1.htm PRESS RELEASE Press Release NVE Corporation Reports First Quarter Results and Announces Quarterly Dividend Revenue increases 81% and net income increases 79% EDEN PRAIRIE, Minn.—July 22, 2026—NVE Corporation (Nasdaq: NVEC) announced today financial result